Primary Care Clinics in Oscoda, MI Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Oscoda Va Outpatient Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 5671 N Skeel Ave, Suite 4, Oscoda, MI 48750 Phone: 989-747-0026 Fax: 989-747-0029 |
Ahc Richardson Elementary School Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3630 E River Rd, Oscoda, MI 48750 Phone: 989-739-2033 |
Ascension St Joseph Hospital Oscoda Health Park Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 5939 N Huron Rd, Oscoda, MI 48750 Phone: 989-739-6081 Fax: 989-739-6093 |
News Archive
BioInvent receives FDA IND clearance for BI-204 Phase II trial in cardiovascular disease
BioInvent International AB today announces IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory processes leading to plaque formation in the blood vessel walls. BI-204 is being co-developed with Genentech for secondary prevention of cardiovascular events in patients with acute coronary syndrome (ACS).
A miRNA signature linked to local-regional failure and overall survival after pancreatic cancer resection
The cover for issue 10 of Oncotarget features Figure 3, "Overall survival (OS) for high (red) versus low (black) risk groups in the (A) OSU, (B) TCGA, and (C) SNU resected cohorts," by Wolfe, et al.
Going global. Scottish online medical specialist signs another international deal with Australian nurse college
Continulus has dramatically widened its global reach with a new collaboration with one of the world's most highly respected nursing bodies.
University of Chicago Celiac Disease Center to host ICDS 2013
The University of Chicago Celiac Disease Center is hosting the 15th International Celiac Disease Symposium (ICDS) on Sept. 22-25, 2013 in Chicago. The symposium is the largest celiac disease and gluten-related disorders conference in the world.
Large trial of tenofovir gel for women set to begin in South Africa
A 24-month clinical trial looking at the effectiveness of tenofovir gel use among women to reduce the risk of HIV infection is set to begin in South Africa in late July or early August, the Mail & Guardian reports.
› Verified 4 days ago